No connection

Search Results

FORA vs LNSR

FORA
Forian Inc.
BEARISH
Price
$2.14
Market Cap
$66.9M
Sector
Healthcare
AI Confidence
80%
LNSR
LENSAR, Inc.
BEARISH
Price
$5.70
Market Cap
$68.9M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
FORA
--
LNSR
--
Forward P/E
FORA
23.78
LNSR
-8.03
P/B Ratio
FORA
2.23
LNSR
-2.63
P/S Ratio
FORA
2.21
LNSR
1.18
EV/EBITDA
FORA
-9.93
LNSR
-3.36

Profitability

Gross Margin
FORA
53.21%
LNSR
46.41%
Operating Margin
FORA
-24.44%
LNSR
-116.03%
Profit Margin
FORA
-9.5%
LNSR
-58.66%
ROE
FORA
-9.61%
LNSR
-1069.41%
ROA
FORA
-5.15%
LNSR
-22.31%

Growth

Revenue Growth
FORA
37.0%
LNSR
-4.2%
Earnings Growth
FORA
--
LNSR
--

Financial Health

Debt/Equity
FORA
0.0
LNSR
--
Current Ratio
FORA
2.96
LNSR
1.15
Quick Ratio
FORA
2.78
LNSR
0.6

Dividends

Dividend Yield
FORA
--
LNSR
--
Payout Ratio
FORA
0.0%
LNSR
0.0%

AI Verdict

FORA BEARISH

FORA exhibits severe fundamental weakness as evidenced by a Piotroski F-Score of 2/9, indicating poor operational efficiency and financial health. While the company maintains a debt-free balance sheet and strong liquidity (Current Ratio 2.96), it is struggling to translate 37% revenue growth into bottom-line profitability. The technical trend is completely bearish (0/100) and the 5-year price performance is devastating (-82.8%), suggesting a long-term loss of investor confidence. Despite a healthy gross margin of 53.21%, the negative operating margins and lack of deterministic value markers make this a high-risk speculative play.

Strengths
Zero debt (Debt/Equity: 0.00)
Strong short-term liquidity (Current Ratio: 2.96)
Robust revenue growth (37% YoY)
Risks
Critically low Piotroski F-Score (2/9) indicating fundamental deterioration
Negative operating margins (-24.44%)
Severe long-term price depreciation (-82.8% over 5 years)
LNSR BEARISH

LNSR exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.63, indicating negative shareholder equity. The company is suffering from catastrophic profitability metrics, including an ROE of -1069.41% and an operating margin of -116.03%. Despite a 'strong_buy' analyst consensus from a very small sample (2 analysts), the fundamental data shows declining revenue (-4.20% YoY) and a consistent failure to meet earnings estimates (0/4 beats in the last year). The technical trend is aggressively bearish, with a 51.6% price collapse in the last month alone.

Strengths
Positive gross margin of 46.41%
Relatively low Price-to-Sales ratio of 1.18
Current ratio of 1.15 provides a marginal liquidity cushion
Risks
Negative equity (P/B -2.63) indicating insolvency risk
Severe operational inefficiency with -116.03% operating margin
Negative revenue growth (-4.20% YoY) suggesting loss of market share

Compare Another Pair

FORA vs LNSR: Head-to-Head Comparison

This page compares Forian Inc. (FORA) and LENSAR, Inc. (LNSR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile